Table 7

Univariate regressions of NMR parameters and medications

NMR parametersPrednisone (n=64)20-day prednisone dose (n=34)Hydroxychloroquine (n=64)Statins (n=64)
Baseline parameters
 Total cholesterol0.045 (0.724)0.243 (0.166)0.082 (0.519)−0.042 (0.740)
 Triglycerides0.143 (0.261)0.405 (0.018)0.178 (0.160)−0.133 (0.294)
 HDL cholesterol0.048 (0.707)−0.021 (0.904)0.009 (0.946)0.123 (0.333)
 LDL cholesterol0.013 (0.918)0.333 (0.054)0.078 (0.542)−0.107 (0.398)
 VLDL triglycerides0.162 (0.200)0.430 (0.011)0.172 (0.174)−0.150 (0.236)
 GlycA0.214 (0.089)0.410 (0.016)0.079 (0.553)0.133 (0.294)
Particle counts
HDL particle count−0.217 (0.086)−0.206 (0.243)−0.067 (0.596)0.136 (0.285)
 Small HDL particle count−0.236 (0.060)0.049 (0.784)−0.111 (0.384)−0.034 (0.790)
 Medium HDL particle count−0.079 (0.536)0.374 (0.029)0.033 (0.795)0.104 (0.415)
 Large HDL particle count0.200 (0.112)0.048 (0.787)0.050 (0.694)0.121 (0.341)
LDL particle count−0.050 (0.694)0.321 (0.065)0.046 (0.717)−0.135 (0.289)
 Small LDL particle count−0.114 (0.370)0.025 (0.889)−0.027 (0.834)−0.088 (0.488)
 Large LDL particle count0.046 (0.716)0.338 (0.050)0.112 (0.380)−0.038 (0.764)
IDL particle count0.124 (0.327)0.011 (0.951)−0.028 (0.826)−0.083 (0.516)
VLDL particle count0.179 (0.157)0.468 (0.005)0.115 (0.365)−0.114 (0.368)
 Small VLDL particle count0.136 (0.283)0.340 (0.049)0.093 (0.467)−0.027 (0.831)
 Medium VLDL particle count0.172 (0.173)0.419 (0.014)0.074 (0.561)−0.162 (0.202)
Large medium VLDL particle count0.156 (0.219)0.424 (0.013)0.095 (0.453)−0.161 (0.203)
 Large VLDL particle count0.033 (0.793)0.194 (0.271)0.183 (0.149)−0.048 (0.706)
Particle size
 HDL particle size0.184 (0.147)−0.063 (0.725)0.036 (0.778)0.069 (0.588)
 LDL particle size0.063 (0.619)0.003 (0.985)0.121 (0.342)0.086 (0.498)
 VLDL particle size0.094 (0.459)0.112 (0.529)0.081 (0.523)0.022 (0.863)
  • Univariate regressions reported as β-coefficient (p value).

  • Parameters reaching significance (p<0.05) highlighted in bold; after controlling for multiple comparisons only those with p<0.00009 remain statistically significant.

  • GlycA, glycoprotein acetylation; HDL, high-density lipoprotein; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; NMR, nuclear MR; VLDL, very low-density lipoprotein.